Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Journal of Pediatric Gastroenterology and Nutrition|March 24, 2025
Vitamin D status in children undergoing allogeneic hematopoietic stem cell transplantation: A prospective exploratory studyJanne Anita Kvammen, Rut Anne Thomassen, Jochen Buechner, et al.
Blood Advances|March 29, 2024
Pharmacokinetics, pharmacodynamics, efficacy, and safety of ravulizumab in pediatric paroxysmal nocturnal hemoglobinuriaSatheesh Chonat, Alexander Kulagin, Alexey Maschan, et al.
Aging Cell|February 4, 2019
Epigenetic age is a cell-intrinsic property in transplanted human hematopoietic cellsArne Søraas, Mieko Matsuyama, Marcos de Lima, et al.
Aging Cell|March 5, 2024
Epigenetic aging of human blood cells is influenced by the age of the host bodyPetter Holland, Mette Istre, Maryan M Ali, et al.
Blood Advances|January 26, 2021
Practical guidelines for monitoring and management of coagulopathy following tisagenlecleucel CAR T-cell therapyJochen Buechner, Stephan A Grupp, Hidefumi Hiramatsu, et al.
Leukemia|April 15, 2022
Tisagenlecleucel in pediatric and young adult patients with Down syndrome-associated relapsed/refractory acute lymphoblastic leukemiaTheodore W Laetsch, Shannon L Maude, Adriana Balduzzi, et al.
Transplantation and Cellular Therapy|November 1, 2025
Opportunities and Challenges With CAR T-cell Treatment of Children and Young Adults With B-Cell Acute Lymphoblastic Leukemia: Review and Recommendations From the Westhafen Intercontinental GroupCandelaria Deimundo Roura, Persis Amrolia, Marc Ansari, et al.
British Journal of Haematology|January 26, 2019
Low burden of minimal residual disease prior to transplantation in children with very high risk acute lymphoblastic leukaemia: The NOPHO ALL2008 experienceMarianne Ifversen, Dominik Turkiewicz, Hanne V Marquart, et al.
Journal of Clinical Immunology|December 11, 2021
A Nationwide Study of GATA2 Deficiency in Norway-the Majority of Patients Have Undergone Allo-HSCTSilje F Jørgensen, Jochen Buechner, Anders E Myhre, et al.
Blood Advances|September 22, 2023
Low rate of nonrelapse mortality in under-4-year-olds with ALL given chemotherapeutic conditioning for HSCT: a phase 3 FORUM studyPeter Bader, Ulrike Pötschger, Jean-Hugues Dalle, et al.
Pageof 7